A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-07-25. Anything still debated is marked as such rather than presented as settled.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
As of today and for the next few hundred years or so, caesium-137 and strontium-90 continue to be the principal source of radiation in the zone of alienation around the Chernobyl nuclear power plant, and pose the greatest risk to health, owing to their approximately 30-year half-life and biological uptake. An estimated area of 12000 km² of Germany is contaminated with caesium-137 following the Chernobyl disaster in 1986 with surface activity of 20 to 37 kBq/m2. This corresponds to 1.1% of all caesium-137 released in Europe after the Chernobyl accident. In Scandinavia, some reindeer and sheep exceeded the Norwegian legal limit (3000 Bq/kg) 26 years after Chernobyl. The Chernobyl caesium-137 has now decayed by more than half, but could have been locally concentrated by much larger factors.
=== Preclinical studies === Gemigliptin is a competitive, reversible DPP-4 inhibitor (Ki = 7.25 ± 0.67 nM) with excellent selectivity over other critical human proteases such as DPP-2, DPP-8, DPP-9, elastase, trypsin, urokinase and cathepsin G. The kinetics of DPP-4 inhibition by gemigliptin was characterized by a fast association and a slow dissociation rate compared to sitagliptin (fast on and fast off rate) or vildagliptin (slow on and slow off rate). Gemigliptin was rapidly absorbed after single oral dosing and the compound was eliminated with a half-life of 3.6 h, 5.2 h, and 5.4 h in the rat, dog, and monkey, respectively. The bioavailability of gemigliptin in the rat, dog, and monkey was species-dependent with the values of 94%, 73%, and 26%, respectively. Following the oral administration of gemigliptin in the rat, dog and monkey, about 80% inhibition of plasma DPP-4 activity were observed at the plasma levels of 18 nM, 14 nM and 4 nM, respectively. In a diet-induced obesity model, gemigliptin reduced glucose excursion during OGTT in a dose dependent manner with the minimum effective dose of 0.3 mg/kg and enhanced glucose-stimulated plasma GLP-1 increase in a dose dependent manner reaching the maximum effect at the dose of 1 mg/kg. Following 4 week oral repeat dosing in the DIO mice, gemigliptin reduced significantly HbA1c with the minimum effective dose of 3 mg/kg. In the beagle dog, gemigliptin significantly enhanced active GLP-1, decreased glucagon, and reduced glucose excursion during OGTT following a single dosing.
== Subcellular distribution == Most members of the SLC group are located in the cell membrane, but some members are located in mitochondria (the most notable one being SLC family 25) or other intracellular organelles.
The plebiscite areas (German: Abstimmungsgebiete; French: zones du plébiscite) were placed under the authority of two Inter-Allied Commissions of five members, who were appointed by the Principal Allied and Associated Powers representing the League of Nations. British and Italian troops, under the command of the Commissions, arrived on and soon after 12 February 1920 after the regular German Reichswehr had previously left the plebiscite areas. The civil and municipal administration was continued by the existing German authorities, which were responsible to the Commissions for their duration. In accordance with Articles 94 to 97 of the Treaty of Versailles (section entitled "East Prussia"), the Marienwerder Plebiscite Area was formed of northeastern Marienwerder Government Region, based in Marienwerder in West Prussia, now Kwidzyn, which encompassed the districts of Marienwerder (east of the Vistula), Stuhm (based in Stuhm, now Sztum), Rosenberg (based in Rosenberg in West Prussia, now Susz) as well as parts of Marienburg in West Prussia (based in Marienburg in West Prussia, Malbork, part of the Danzig Government Region) east of the Nogat. The treaty defined the Allenstein Plebiscite Area as "The western and northern boundary of Allenstein Government Region to its junction with the boundary between the districts of Oletzko (based in Marggrabowa, now Olecko) and of Angerburg (based in Angerburg, now Węgorzewo).
=== Russia and Ukraine === From 2013 to 2022 Galloway was a presenter on the Russian state-controlled television network RT. Galloway called the 2014 Ukrainian Revolution a Western-backed "coup" and a "foreign financed invasion of the sovereignty of Ukraine". He believes Russia's annexation of Crimea was legitimate, because he said the disputed 2014 Crimean status referendum showed that "the huge majority of people in Crimea wanted to leave Ukraine". In a 2016 interview of Nigel Farage, Galloway said "I respect Putin and I think he's very popular in Russia". When Russian opposition leader Alexei Navalny was poisoned in August 2020, Galloway claimed on RT that Navalny was a white supremacist. In early 2022, Galloway dismissed claims that Russia was about to invade Ukraine, writing "I told you it wasn't. You were wrong. I was right". When Russia invaded Ukraine ten days later, he said the invasion was "not what I wanted", but he blamed the invasion on "the West" and accused it of "Pumping Ukraine full of NATO weapons, mercenaries and propaganda". He suggested that the Bucha massacre was staged. Galloway was accused of being an apologist and propagandist for Russian president Vladimir Putin by the larger political parties. Jamie Blackett ended their political alliance All for Unity over their disagreement on Ukraine. The Scottish Liberal Democrats leader, Alex Cole-Hamilton, called Galloway "an apologist for Russian expansionist aggression" and said that Galloway's "association with RT has lent legitimacy and influence to the propaganda apparatus of a hostile power".
Sources: en.wikipedia.org
Nearer Secret of Life." The news reached readers of The New York Times the next day; Victor K. McElheny, in researching his biography, "Watson and DNA: Making a Scientific Revolution", found a clipping of a six-paragraph New York Times article written from London and dated 16 May 1953 with the headline "Form of 'Life Unit' in Cell Is Scanned". The article ran in an early edition and was then pulled to make space for news deemed more important. (The New York Times subsequently ran a longer article on 12 June 1953). The university's undergraduate newspaper Varsity also ran its own short article on the discovery on Saturday 30 May 1953. Bragg's original announcement of the discovery at a Solvay conference on proteins in Belgium on 8 April 1953 went unreported by the British press. In a seven-page, handwritten letter to his son at a British boarding school on 19 March 1953 Crick explained his discovery, beginning the letter "My Dear Michael, Jim Watson and I have probably made a most important discovery". The letter was put up for auction at Christie's New York on 10 April 2013 with an estimate of $1 to $2 million, eventually selling for $6,059,750, the largest amount ever paid for a letter at auction. Sydney Brenner, Jack Dunitz, Dorothy Hodgkin, Leslie Orgel, and Beryl M Oughton, were some of the first people in April 1953 to see the model of the structure of DNA, constructed by Crick and Watson; at the time they were working at Oxford University's Chemistry Department.
Half-Life: Echoes – Having a greater emphasis on survival horror than the base game, the player controls an unnamed scientist at the Black Mesa Research Facility surviving the Resonance Cascade and invasion by Xen and HECU forces. Point of View – A mod released on May 2, 2003 by the developers of Azure Sheep. The player character is a vortigaunt named Xonxt. The player can only use alien weaponry and has no armor. Medkits can't be used, instead Xen healing pools have to be used for restoring health. The Games Machine gave the mod a positive review. PC Zone gave the mod a rating of 76 out of 100 and called it "a refreshing alternative". Poke646 – Released in December 2001. Takes place after the events of Half-Life in Nation City. Features new weapons and textures. Named often one of the best single-player mods for Half-Life. Poke646: Vendetta – Released in December 2006. Sequel to Poke646. Received a positive review by PC Action. They Hunger – This is a single-player horror-based mod. It was released by Neil Manke's Black Widow Games in three episodes, the first in 1999, the second in 2000, and the final installment in 2001. All three were at one point bundled with PC Gamer magazine. USS Darkstar – A mod by Neil Manke, produced by PC Gamer and released on July 14, 1999. This mod follows a scientist on a deep-space scientific mission aboard an interstellar spacecraft. When an experiment goes awry, the player has to defend himself against aliens. The mod was first released on the PC Gamer website and was featured on the magazine's demo CD in August 1999.
In accordance, studies of the amount of oral estradiol necessary for endometrial proliferation in women have reported a total dose of 60 mg for micronized estradiol relative to 120 to 300 mg or more for non-micronized estradiol. As such, micronization has been said to substantially improve the potency of oral estradiol.
The androgen backdoor pathway (the backdoor pathway of androgen biosynthesis) is a metabolic route in which androgens are produced from 21-carbon (C21) steroids bypassing testosterone and androstenedione as intermediates. This process starts with 21-carbon (C21) steroids, also known as pregnanes, and involves a step called "5α-reduction". This pathway does not require the intermediate formation of testosterone, hence the term "bypassing testosterone" is sometimes used in medical literature as the hallmark feature of this way of androgen biosynthesis. This feature is a key distinction from the conventional, canonical androgenic pathway, which necessitates the involvement of testosterone as an intermediate in the synthesis of androgens. These alternate androgen pathways are active in early male sexual development. In individuals with congenital adrenal hyperplasia due to enzyme deficiencies like 21-hydroxylase or cytochrome P450 oxidoreductase deficiency, these pathways can activate at any age with increased levels of precursors like progesterone or 17α-hydroxyprogesterone. This activation can lead to symptoms of hyperandrogenism such as acne, hirsutism, polycystic ovarian syndrome, or prostate enlargement. In the canonical pathway, dihydrotestosterone is directly synthesized from testosterone by the enzyme 5α-reductase, primarily in tissues where it exerts its effect, such as the prostate gland, hair follicles, and skin.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.